The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Insulin resistance, secretion, and metabolism in users of oral contraceptives
Abstract
Studies of insulin employing the oral glucose tolerance test demonstrate marked differences between the effects of different oral contraceptives, but provide little insight into the underlying disturbances. We investigated the metabolic basis of these disturbances by computer modelling of iv glucose tolerance test glucose, insulin, and C-peptide concentration profiles. Insulin resistance, secretion, and metabolism were evaluated in 296 oral contraceptive users and 95 nonusers. Four estrogen/progestin combinations, with similar estrogen but differing progestin contents, and 1 progestin-only formulation were studied. Effects on iv glucose tolerance test glucose, insulin, and C-peptide concentrations varied according to progestin content, with levonorgestrel-containing combinations having the greatest effect, followed by desogestrel and norethindrone. However, these formulations increased insulin resistance to a similar extent. The progestin-only formulation did not affect insulin resistance. Levonorgestrel combinations increased second phase pancreatic insulin secretion by 60-90%, but did not affect the insulin half-life. The desogestrel combination increased the insulin half-life by 28%, but did not affect insulin secretion. The effects of different combined oral contraceptives on glucose tolerance test glucose, insulin, and C-peptide concentration profiles appears to be due to a combination of estrogen-induced insulin resistance and progestin-associated changes in insulin half-life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417
Self-citationToffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Mechanism of hypertriglyceridaemia associated with contraceptive steroids.
Kissebah, A., Harrigan, P., & Wynn, V. (1973) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093969 · Cited by 106
Self-citationSKOUBY, S. O., ANDERSEN, O., SAURBREY, N., & KÜHL, C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-3-519 · Cited by 83
Cited by
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Estrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
Obesity and reproductive disorders in women
Pasquali, R. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg024 · Cited by 539
Induction of insulin resistance by androgens and estrogens
Polderman, K. H. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.265 · Cited by 380
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Solomon, C. G. (2001) · JAMA · doi:10.1001/jama.286.19.2421 · Cited by 362
Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects
Elbers, J. M. H., Giltay, E. J., Teerlink, T., Scheffer, P. G., Asscheman, H., Seidell, J. C., & Gooren, L. J. G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01753.x · Cited by 319
Sex steroids and insulin resistance
LIVINGSTONE, C., & COLLISON, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 309
Cigarette smoking and diabetes
Eliasson, B. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.00103 · Cited by 294
Holte, J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1052 · Cited by 290
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
De Leo, V., la Marca, A., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 286
Sex hormone binding globulin and insulin resistance
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12086 · Cited by 268
Clausen, J. O., Borch-Johnsen, K., Ibsen, H., Bergman, R. N., Hougaard, P., Winther, K., & Pedersen, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118903 · Cited by 259
Sitruk-Ware, R., & Nath, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.09.004 · Cited by 247
Metabolic effects of contraceptive steroids
Sitruk-Ware, R., & Nath, A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9182-4 · Cited by 161
Meyer, C., McGrath, B. P., & Teede, H. J. (2007) · Diabetes Care · doi:10.2337/dc06-0618 · Cited by 148
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593446 · Cited by 140
Dahlgren, E., Landin, K., Krotkiewski, M., Holm, G., & Janson, P. O. (1998) · Human Reproduction · doi:10.1093/humrep/13.10.2706 · Cited by 118
Piltonen, T., Puurunen, J., Hedberg, P., Ruokonen, A., Mutt, S. J., Herzig, K. H., Nissinen, A., Morin-Papunen, L., & Tapanainen, J. S. (2012) · Human Reproduction · doi:10.1093/humrep/des225 · Cited by 94
Sex Hormones, Insulin Sensitivity, and Diabetes Mellitus
Bruns, C. M., & Kemnitz, J. W. (2004) · ILAR Journal · doi:10.1093/ilar.45.2.160 · Cited by 79
Metabolic impact of combined hormonal contraceptives containing estradiol
Grandi, G., Napolitano, A., & Cagnacci, A. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1190832 · Cited by 50
Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion
Watanabe, R. M., Steil, G. M., & Bergman, R. N. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.1.e172 · Cited by 35
LEGATO, M. J. (1998) · Journal of Women's Health · doi:10.1089/jwh.1998.7.199 · Cited by 22
“…and not to estrogen in the combination.57 Other work shows that OCs induce insulin resistance and that progestin prolongs the half-life of insulin.58 Hannaford et al.59 studied the vulnerability to stroke of women using OCs and found that current users of OCs were at increased risk of stroke but…”
Haverinen, A., Kangasniemi, M., Luiro, K., Piltonen, T., Heikinheimo, O., & Tapanainen, J. S. (2021) · Contraception · doi:10.1016/j.contraception.2020.10.014 · Cited by 17
Metadata
- Authors
- Godsland, I. F.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1992-01-01
- Volume
- 74
- Issue
- 1
- Pages
- 64-70
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2030579450
- Cited by
- 251
- References
- 5
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.